CLINICAL_TRIALS
trial_result
· 2012-01-20
Clinical Trial Update: Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome [Phase 2]
Summary
Phase 2 trial evaluating AGN 203818 for pain in fibromyalgia; the study was terminated and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Fibromyalgia | Phase 2 | Status: TERMINATED | Results posted: 2012-01-20